Top Banner

of 28

Anemia in Pregnancy

Mar 27, 2016

Download

Documents

Ratna Ekawati

catatan kuliah anemia pada kehamilan
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
  • Anemia in PregnancyDetty NurdiatiDetty Nurdiati

    Dept of Obstetric & GynecologyFaculty of Medicine, Gadjah Mada University

    Dr. Sardjito Hospital. Yogyakarta

  • Higher mortality

    rate

    Impaired mental development

    Increased risk of adult chronic disease

    Baby

    Impaired immunity

    Cycle: Nutrition, Health and their Consequences

    Untimely / inadequate weaning

    Frequent infections

    Inadequate food, health

    & careInadequate food,

    health& care

    Reduced capacity to care for baby

    Inadequate fetal nutrition

    Baby Low Birth Weight

    Inadequate catch up growth

    Child

    Elderly Malnourished

    Anemia

    AnemiaInfectione.g. malaria

    Reduced mental capacity

    Inadequate food, health &

    care

    Reduced mental capacityInadequate food, health & careHigher maternal mortality

    PregnancyLow Weight Gain

    Micronutrient deficiencies

    WomanMalnourished

    Adolescent Stunted

    Child StuntedAnemia

  • Objectives

    Understand the physiological changes of the blood in pregnancyblood in pregnancy

    Know the maternal and effect of anemia

    Understand the cause of anemia in pregnancy

    Be able to detect and manage anemia Be able to detect and manage anemia antenatally

  • Physiological Changes

    Blood volume normally 36% max being reached at 34 weeks

    Plasma volume 47-50% Red cell mass 17-25%

    Relative hemodilution throughout the pregnancy

    Reaches its maximum between 28-34 weeks

  • Physiological Changes

    Consequent of hemodiltuion in Hb, Hct, RBC

    MCV and MCHC remains stable The MCV secondary to erythropoiesis These indices decrease progressively in IDA

    Serum iron & ferritin secondary to Serum iron & ferritin secondary to utilization

    Total iron-binding capacity

  • Physiological Changes

    Iron requirement Due to expanding red cell mass & fetal requirements Due to expanding red cell mass & fetal requirements

    2.5 mg/day in trim 1 to 6.6 mg/day in trim 3

    700-1400 mg total pregnancy

    Iron absorption moderately Folate requirements

    Due to the fetus, placenta, uterus and expanded maternal Due to the fetus, placenta, uterus and expanded maternal and red cell mass

    No major effect on B12 stores, although levels (preferential active transport to fetus)

  • Dietary Iron RequirementsThroughout the Life Cycle

    Required iron intake(mg Fe/1000 kcal)

    Pregnancy

    4

    6

    8

    10

    12

    Men

    Women

    Pregnancy

    0

    2

    0 10 20 30 40 50 60 70

    Stoltzfus, 1997

    Age (years)

  • Anemia

    Definition: A pathological condition in which the oxygen-

    carrying capacity of RBC in insufficient to meet the bodys need

    Diagnosis is based on the Hb concentration: WHO: < 11g/dL at any time during pregnancy

    Clinicians: Trim I and III : < 11 g/dL

    Trim II : < 10.5 g/dL

  • Incidence

    The commonest medical disorder of pregnancypregnancy

    30-50% of pregnant women 90% iron deficiency

    5% folate deficiency

  • Clinical Features

    Often asymptomatic

    Diagnosis being made on routine screening Estimating the Hb concentration The beginning of pregnancy and

    Again later in pregnancy

  • Consequencesof Maternal Anemia

    Maternal deaths

    Reduced transfer of iron to fetus Reduced transfer of iron to fetus

    Low birth weight

    Neonatal mortality

    Reduced physical capacity Reduced physical capacity

    Impaired cognition

  • Anemia and ObstetricalHemorrhage

    Anemia does not cause obstetrical hemorrhage Anemia does not cause obstetrical hemorrhage Etiology of obstetric hemorrhage Early pregnancy: Abortion complications Mid/late pregnancy to delivery: Previa, abruption,

    atony, retained placenta, birth canal laceration

    Primary factors affecting outcome:Primary factors affecting outcome: Rapid intervention to prevent exsanguination Availability of skilled provider, drugs, blood and fluids

    There is no evidence that high levels of Hb are beneficial in withstanding a hemorrhagic event.Enkin et al 2000; Mahomed 2000a.

  • Severe Anemia andMaternal Mortality (Malaysia)

    20Maternal deaths / 1000 live births

    15.5

    3.5

    10

    20

    0

    Llewellyn-Jones, 1985

    < 65 > 65Pregnancy hemoglobin concentration (g/L)

  • Pregnancy Hemoglobinand Low Birth Weight

    13.815 13.8

    11.59.7 8.9 9

    11.4 11

    0

    5

    10

    15

    80 90 100 110 120 130 140

    % L

    ow

    bir

    th w

    eig

    ht

    80 90 100 110 120 130 140

    Lowest pregnancy hemoglobin concentration (g/L)

    Garn et al., 1981

  • Iron Deficiency Anemia

    Microcytic, hypochromic anemia because of the reduced of MCV and MCHCthe reduced of MCV and MCHC

    Significant iron demands during pregnancy Secondary to expanding red cell mass and fetal

    requirements

    Can only be met by a limited increase in iron absorption and by the utilization of iron stores

    If the iron stores already depleted anemia will develop rapidly.

  • Iron Deficiency Anemia

    The total iron-binding capacity (TIBC) increases secondary to the increased plasma volume and secondary to the increased plasma volume and the serum iron falls

    As iron demands exceed during the pregnancy, ferritin levels fall

    Decreased Hb concentration is a late event in iron deficiency anemiadeficiency anemia

  • Concequences

    The impaired function of iron-dependent enzymes causes alterations in muscle neurotransmitter activity and causes alterations in muscle neurotransmitter activity and epithelial changes throughout the body

    The basis explanation for the apparent link between IDA and preterm delivery, infection medical intervention during labour and postpartum hemorrhage

    Fetal perspectiveIncreased risk of preterm delivery and IUGR Increased risk of preterm delivery and IUGR

    Increased risk the low neonatal iron status, the impairment of cognitive development and behaviour of babies

  • Diagnosis

    ID can be present in the absence of anemia and other parameter of the full blood count and other parameter of the full blood count that usually give a clue to this (reduced MCV and MCHC) are not accurate during pregnancy

    The diagnosis test for ID is The diagnosis test for ID is a ferritin concentration, which is not affected by

    pregnancy

    The concentration of

  • Treatment

    Oral iron replacementEffective if there is enough time maximum Effective if there is enough time maximum increase HB: 0.8 g/dL per week

    Recommended dose: 120-240 of elemental iron per day

    Ferrous salts are absorted better than ferric salts, should be used in preference

    Vit C aids the iron absorption 40% increased of side effect, mainly

    gastrointestinal effect on compliance

  • Treatment

    Intramuscular Iron Iron sorbitol injection has a low molecular rapid Iron sorbitol injection has a low molecular rapid

    absorption Intravenous iron

    Iron sucrose is licensed for total dose iron replacement in the trim 2 and 3.

    More effective & less side effect Blood transfusion

    Towards the end of pregnancy Towards the end of pregnancy Rapid increase of Hb concentration but not iron stores

    Erythropoietin Mainly used for the anemia associated with erythropoietin

    deficiency in CRF, but can also be used to increase the autologous production of blood in normal individuals

  • Prevention

    Prevention before pregnancy Balanced diet in the absence of ongoing blood loss

    Identification and treatment of IDA prior to pregnancy

    Prevention during pregnancy Routine iron supplementation 60 mg/day elemental Routine iron supplementation 60 mg/day elemental

    iron

    Improvement in hematological indices

  • Folate Deficiency

    Increase of folate requirements because of the increased cell replication that is taking place in

    the fetus, uterus and bone marrow (increase red cell mass)

    Plasma folate decrease during pregnancy

    Reaching half non pregnant levels by term

    Folate deficiency causes a megaloblastic anemia

  • Concequences

    Fetal perspective:Clear link preconceptual folate deficiency and Clear link preconceptual folate deficiency and NTD

    All women planning a pregnancy should take 400 ug/day folic acid the first 12 weeks the neural tube is closed

    Maternal perspective: Maternal perspective: Anemia Involvement of tissues with high rates of cell

    turnovers, in particular mucous membranes the folate deficiency can be exacerbated by malabsorption if the gut mucosa is affected

  • Diagnosis

    Outside pregnancy Macrocytic of folate deficiency anemia is

    diagnosed by an increased of MCV

    In pregnancy the MCV is increased

    May be masked by co-existing iron deficiency May be masked by co-existing iron deficiency leading to reduced MCV.

    Examining the blood film may be useful bone marrow aspiration

  • Treatment

    Severe folate deficiency is extremely rare

    But if it happened, the treatment is difficult due to poor folate absorption from the affected gastrointestinal tract

    5 mg oral pteroglutamic acid daily or parenteral folate can be usedparenteral folate can be used

  • Prevention

    400 ug/day for the prevention of NTD by 36%

    5 mg/day could reduce the risk of NTD by 85%

  • Vitamin B12 Deficiency

    Rare during the reproductive years

    Absorption unchanged by pregnancy

    Actively transported across the placenta to the fetus

    Management Should be optimized prior to conception Should be optimized prior to conception

    Virtually all animal products will supply enough vit B12